Friday, July 31, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
1 free article left this week. A free account gets you 4 a week.Go Pro →
Market

Daewoong's Nabota Enters Kuwait—Completes 7-Market GCC Sweep

Korean toxin expands across Middle East, signaling aggressive international push and competitive pressure on Allergan and Galderma in high-margin markets.

Image: Inside MedSpa
1-YEAR MOVE
+15% −13%
ABBV ▲11.6%
1-year price move by ticker
TickerCompany1-year change
ABBVAbbVie (Allergan Aesthetics)+11.6%

Daewoong Pharmaceutical announced that its botulinum toxin Nabota has entered Kuwait, marking the seventh Middle Eastern market for the Korean competitor. The expansion completes a strategic sweep of Gulf Cooperation Council (GCC) markets—a region characterized by high aesthetic procedure volume, strong pricing power, and limited regulatory friction.

Nabota has been steadily building international market share, particularly in Asia-Pacific and now the Middle East. The product's entry into Kuwait signals Daewoong's confidence in competing head-to-head with Allergan Aesthetics (Botox) and Galderma (Dysport) in markets where brand loyalty is still forming and pricing is not yet commoditized.

Nabota now in 7 Middle East markets—Korean toxin maker signals aggressive GCC expansion, challenging Allergan and Galderma pricing.

For U.S. and European practices, Nabota's Middle East expansion is a reminder that the global toxin market is fragmenting. Allergan's dominance is eroding in emerging markets where Daewoong and other Korean manufacturers (Hugel, Medytox) offer competitive pricing and regulatory pathways. Practices with international aspirations or supply-chain concerns should monitor Nabota's regulatory trajectory in their home markets.

Source: original report ↗

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/daewoong-nabota-kuwait-seventh-middle-east-market/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo